Qube Research & Technologies LTD Vigil Neuroscience, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 42,585 shares of VIGL stock, worth $69,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,585
Previous 30,429
39.95%
Holding current value
$69,413
Previous $121,000
19.01%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
27.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$9.51 Million2.45% of portfolio
-
Northpond Ventures, LLC4.21MShares$6.87 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$3.25 Million0.34% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$2.96 Million0.2% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.65MShares$2.69 Million1.03% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $46.1M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...